Investment analysts at Lazard Capital Markets upped their price objective on shares of UnitedHealth Group (NYSE:UNH) from $70.00 to $77.00 in a note issued to investors on Friday, StockRatingsNetwork.com reports. The firm currently has a “buy” rating on the stock. Lazard Capital Markets’ price objective suggests a potential upside of 7.77% from the stock’s previous close.
Shares of UnitedHealth Group (NYSE: UNH) traded up 1.28% during mid-day trading on Friday, hitting $71.45. UnitedHealth Group has a 52 week low of $50.32 and a 52 week high of $70.85. The stock’s 50-day moving average is currently $65.12. The company has a market cap of $72.879 billion and a P/E ratio of 13.75.
UnitedHealth Group (NYSE:UNH) last released its earnings data on Thursday, July 18th. The company reported $1.40 EPS for the quarter, beating the Thomson Reuters consensus estimate of $1.25 by $0.15. The company had revenue of $30.40 billion for the quarter, compared to the consensus estimate of $30.48 billion. During the same quarter in the previous year, the company posted $1.27 earnings per share. The company’s revenue for the quarter was up 11.5% on a year-over-year basis. UnitedHealth Group has set its FY13 guidance at $5.35-5.50 EPS. On average, analysts predict that UnitedHealth Group will post $5.46 earnings per share for the current fiscal year.
UNH has been the subject of a number of other recent research reports. Analysts at Jefferies Group raised their price target on shares of UnitedHealth Group from $78.00 to $82.00 in a research note to investors on Friday. Separately, analysts at Oppenheimer raised their price target on shares of UnitedHealth Group from $66.00 to $78.00 in a research note to investors on Friday. They now have an “outperform” rating on the stock. Finally, analysts at Cantor Fitzgerald raised their price target on shares of UnitedHealth Group from $70.00 to $75.00 in a research note to investors on Thursday. They now have a “buy” rating on the stock.
Three investment analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have issued a strong buy rating to the stock. UnitedHealth Group presently has a consensus rating of “Buy” and an average price target of $72.39.
UnitedHealth Group Incorporated (NYSE: UNH) diversified health and well-being company.
